Research Reference
Endoluten
Pineal gland peptide bioregulator for melatonin regulation
Research & educational purposes only. BioMaxFit does not sell, promote, or represent peptides in any way. We are strictly educational and recommend working with your doctor on anything health-related. The information below comes from published research and documents what has been studied, not what should be done. Many of these compounds are investigational and not approved by the FDA; possession or use outside an authorized clinical trial may be illegal in your jurisdiction. This is not medical advice.
Preclinical-Only — For Educational Purposes Only
This compound has no established human dosing. The information below documents preclinical (animal) findings and is provided for research and educational reference only. It is not medical advice or a dosing recommendation.
Endoluten is a pineal gland peptide bioregulator studied for melatonin regulation in preclinical research. There is no established human dosing.
Reconstitution
Endoluten is a peptide bioregulator complex (pineal-derived) developed in the Russian Federation and registered there. It is supplied as capsules or a lyophilized vial for oral or subcutaneous use. It is not FDA-approved in the United States.
No standardized human reconstitution protocol is established outside the CIS-region registered product. Compounded "research" forms sold online are not FDA-approved.
Cycling Protocol
Studied CIS-region protocols describe Endoluten taken orally (capsules) daily for 1 month, or subcutaneously in short courses, sometimes repeated after 3–6 months. No standardized long-term cycle is established; Endoluten is not FDA-approved and durations are community extrapolation.
Routes of Administration
Subcutaneous (community): Some community protocols describe subcutaneous use in short courses.
Endoluten is not FDA-approved in the US.
Stacking Protocols
| Stack | Components | Purpose | | --- | --- | --- | | Pineal bioregulator | Endoluten + Epitalon / Pinealon | Combined CIS-region pineal bioregulators (community) |
Stacking combinations are community extrapolation. Endoluten is not FDA-approved.
Side Effects & Safety
- No human safety database in US frameworks — Endoluten is not FDA-approved and Western safety data is limited
- Generally described as well-tolerated in the published CIS-region literature at studied doses
- Allergic reactions — rare
Endoluten is not FDA-approved in the United States. It is registered in some other countries. Compounded research-peptide forms are not FDA-approved.
Research Basis
Endoluten is a peptide bioregulator complex derived from pineal gland tissue, developed in the Russian Federation (St. Petersburg Institute of Bioregulation and Gerontology).
Mechanism: Described as a tissue-specific bioregulator supporting pineal gland function, melatonin production, and neuroendocrine/immune regulation; studied for longevity and anti-aging effects.
Clinical evidence: Published CIS-region studies describe use in aging, immune, and neuroendocrine contexts, typically as oral or short injection courses. Not FDA-approved in the US; Western trial data is limited.
Not FDA-approved in the US. Compounded research-peptide forms are sold for research purposes only.